Search by Drug Name or NDC
NDC 63629-9278-01 Albendazole 200 mg/1 Details
Albendazole 200 mg/1
Albendazole is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is ALBENDAZOLE.
MedlinePlus Drug Summary
Albendazole is used to treat neurocysticercosis (infection caused by the pork tapeworm in the muscles, brain, and eyes that may cause seizures, brain swelling, and vision problems). Albendazole is also used along with surgery to treat cystic hydatid disease (infection caused by the dog tapeworm in the liver, lung, and lining of the abdomen that may damage these organs). Albendazole is in a class of medications called antihelmintics. It works by killing the worms.
Related Packages: 63629-9278-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Albendazole
Product Information
NDC | 63629-9278 |
---|---|
Product ID | 63629-9278_b0ca1b60-e9e3-4bd9-b376-0b0217881872 |
Associated GPIs | 15000002000320 |
GCN Sequence Number | 019283 |
GCN Sequence Number Description | albendazole TABLET 200 MG ORAL |
HIC3 | W4L |
HIC3 Description | ANTHELMINTICS |
GCN | 53290 |
HICL Sequence Number | 007864 |
HICL Sequence Number Description | ALBENDAZOLE |
Brand/Generic | Generic |
Proprietary Name | Albendazole |
Proprietary Name Suffix | 200 mg |
Non-Proprietary Name | Albendazole |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET, FILM COATED |
Route | ORAL |
Active Ingredient Strength | 200 |
Active Ingredient Units | mg/1 |
Substance Name | ALBENDAZOLE |
Labeler Name | Bryant Ranch Prepack |
Pharmaceutical Class | Anthelmintic [EPC], Cytochrome P450 1A Inducers [MoA] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA210011 |
Listing Certified Through | 2024-12-31 |
Package
NDC 63629-9278-01 (63629927801)
NDC Package Code | 63629-9278-1 |
---|---|
Billing NDC | 63629927801 |
Package | 2 TABLET, FILM COATED in 1 BOTTLE (63629-9278-1) |
Marketing Start Date | 2022-06-06 |
NDC Exclude Flag | N |
Pricing Information | N/A |